Complete Mobile Drug Testing vs Bio-One
Franchise Comparison 2026
Both Complete Mobile Drug Testing and Bio-One are healthcare franchises. Complete Mobile Drug Testing requires an investment of $68K – $288K while Bio-One requires $135K – $221K. Complete Mobile Drug Testing discloses average revenue of $889K; Bio-One does not report Item 19 data. Note: Company-owned outlets only - not franchisee performance; Based on a single outlet - not a system average. Bio-One has SBA lending data on file with a 8.1% charge-off rate. FranchiseVerdict rates Complete Mobile Drug Testing C (Average) and Bio-One B (Above average).
| Metric | Complete Mobile Drug Testing | Bio-One |
|---|---|---|
| Verdict Grade | CAverageAverage | BAbove averageAbove average |
| Investment Range | $68K – $288K | $135K – $221K |
| Franchise Fee | $55K | $60K |
| Royalty Rate | 10.0% | Greater of applicable minimum royalty ($750/mo months 1-12, $1,500/mo months 13-24, $2,250/mo months 25+) or 7.5% of Gross Sales |
| Average Revenue (Item 19) | $889KCompany-owned only · n=1 | N/AOutlet subset |
| SBA Charge-Off Rate | N/A | 8.1% (74 loans) |
| Total Units | 1 | 137 |
| Unit Growth (YoY) | N/A | N/A |
| Year Began Franchising | 2025 | 2010 |
| FDD Year | 2026 | 2025 |
Investment Range
$68K – $288K
$135K – $221K
Franchise Fee
$55K
$60K
Royalty Rate
10.0%
Greater of applicable minimum royalty ($750/mo months 1-12, $1,500/mo months 13-24, $2,250/mo months 25+) or 7.5% of Gross Sales
Average Revenue (Item 19)
$889KCompany-owned only · n=1
N/AOutlet subset
SBA Charge-Off Rate
N/A
8.1% (74 loans)
Total Units
1
137
Unit Growth (YoY)
N/A
N/A
Year Began Franchising
2025
2010
FDD Year
2026
2025